Efnan Algın

9PUBLICATIONS

122CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jun 16, 2026

Low muscle mass predicts poor response to neoadjuvant chemotherapy in advanced ovarian cancer.

|May 27, 2026

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|May 04, 2026

A Machine Learning Framework for Prognostic Modeling in Stage III Colon Cancer.

|Feb 27, 2026

Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Baris Koksal, Hasan Cagri Yildirim, Deniz Can Guven

|Oct 29, 2025

Clinicopathologic Disease Characteristics and Their Association with Adjuvant Chemotherapy Outcomes in Pulmonary Large-Cell Carcinoma Patients with or Without Neuroendocrine Features.

Doğan Bayram, Oznur Bal, Efe Cem Erdat

|Jul 20, 2024

A propensity score-matched comparison of neoadjuvant chemoradiotherapy with cisplatin-5FU and carboplatin-paclitaxel in locally advanced esophageal squamous cell carcinoma: A Turkish oncology group study.

Fatih Gürler, Fatih Tay, Zehra Sucuoğlu İşleyen

Pageof 2

Frequent Collaborators

Öznur Bal

Elif Sahin

Hasan Çağrı Yıldırım

Nargiz Majidova

Murat Bardakçı

Sedat Biter

Ozkan Alan

Doğan Uncu

Doğan Bayram

Sinem Akbas

Frequent Collaborators

Öznur Bal

Elif Sahin

Hasan Çağrı Yıldırım

Nargiz Majidova